We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

ACCeptation and Qualitative Evaluation of Phone-delivered Intervention (ACCEPT-S)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02949453
Recruitment Status : Recruiting
First Posted : October 31, 2016
Last Update Posted : April 4, 2017
Sponsor:
Collaborator:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Background: Previous suicide attempt is known to be a strong risk factor for repetition and repetition is common within the first year after an episode of deliberate self-harm (DSH). There has been growing interest in brief interventions for this population that are focused on maintaining long-term contact and/or offering re-engagement with services when needed. Despite telephone-delivered interventions have shown promising results in suicide reattempt prevention, subjective impact of such brief contact interventions and effectiveness mechanisms have never been evaluated.

Condition or disease Intervention/treatment
Suicide Behavioral: Semi-directed interview performed by a social sciences researcher

Detailed Description:
Semi-structured in-depth interviews with 20 patients previously receiving a telephone-delivered intervention from our team. Six weeks and 3 months after a DSH, people included in telephone-delivered process will be interviewed by a social science researcher. Qualitative analysis using thematic analysis will be independently performed by two researchers.

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: ACCeptation and Qualitative Evaluation of Phone-delivered Intervention To Prevent Suicide Reattempt
Actual Study Start Date : March 3, 2017
Estimated Primary Completion Date : November 30, 2018
Estimated Study Completion Date : November 30, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Self-harm Suicide
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: patients after suicidal episode
Patients receiving a telephone-delivered intervention after deliberate self-harm (DSH)
Behavioral: Semi-directed interview performed by a social sciences researcher

Two semi-directed interviews performed by social sciences researcher:

  • first interview performed 6 weeks after the suicide attempt, in an suicide prevention unit, duration 1 to 1.5 hour
  • second interview performed 3 month after the suicide attempt, in a suicide prevention unit, duration 1 to 1.5 hour


Outcome Measures

Primary Outcome Measures :
  1. Acceptation of a telephone-delivered intervention after deliberate self-harm(DSH) [ Time Frame: change from baseline after the telephone intervention ]
    analyze the acceptability for suicidal patients in the reiteration of the suicide prevention procedure performed by telephone Callback


Secondary Outcome Measures :
  1. Impact of telephone-delivered intervention after a deliberate self-harm (DSH) [ Time Frame: 2 years ]
    through the evaluation of this device Callback, we will identify its impact on pipelines and post-crisis experiences


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Deliberate self-harm in the previous week,
  • 18 years old and older,
  • outpatient care orientation after discharge from emergency department

Exclusion Criteria:

  • Difficulties in french language,
  • mental retardation
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02949453


Contacts
Contact: TERRA JEAN-LOUIS, PUPH 0033437915120 jean-louis.terra@ch-le-vinatier.fr
Contact: LEAUNE EDOUARD, CCA 0033437915120 edouard.leaune@ch-le-vinatier.fr

Locations
France
Hopital Vinatier Recruiting
Lyon Bron, France, 69677
Contact: LEAUNE EDOUARD, Dr    +33437915120    edouard.leaune@ch-le-vinatier.fr   
Sponsors and Collaborators
Hôpital le Vinatier
Hospices Civils de Lyon
Investigators
Principal Investigator: TERRA JEAN-LOUIS, PUPH CENTRE HOSPITALIER LE VINATIER
More Information

Responsible Party: Hôpital le Vinatier
ClinicalTrials.gov Identifier: NCT02949453     History of Changes
Other Study ID Numbers: 2016-A00919-42
First Posted: October 31, 2016    Key Record Dates
Last Update Posted: April 4, 2017
Last Verified: April 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Hôpital le Vinatier:
suicide
prevention

Additional relevant MeSH terms:
Suicide
Self-Injurious Behavior
Behavioral Symptoms